Jessica Desjardins

Jessica Desjardins is a highly qualified scientist with extensive experience in virology, immunology, and genetic research. Currently serving as Senior Investigator at Repare Therapeutics since June 2017, Jessica has held multiple titles including Senior Scientist I and II, focusing on CRISPR/Cas9 synthetic lethal screening and target validation. Prior to this, Jessica worked at Vertex Pharmaceuticals as a Principal Research Associate, contributing to primary cell culture and gene editing for kidney diseases. Additional experience includes roles at the Institut Cardiologie de Montréal studying genetic risk factors for myocardial infarction and evaluating antiviral compounds at Boehringer Ingelheim. Jessica holds a Master’s degree in Virology and Immunology from INRS-Institut Armand-Frappier and a Bachelor's degree in Biotechnology from Université de Sherbrooke.